Identification of antibacterial and antiviral activities of novel fused 1,2,4-triazine esters

被引:58
作者
Sztanke, Krzysztof
Pasternak, Kazimierz
Rajtar, Barbara
Sztanke, Malgorzata
Majek, Magdalena
Polz-Dacewicz, Malgorzata
机构
[1] Prof Feliks Skubiszewski Med Univ, Dept Med Chem, PL-20081 Lublin, Poland
[2] Prof Feliks Skubiszewski Med Univ, Dept Virol, PL-20093 Lublin, Poland
[3] Prof Feliks Skubiszewski Med Univ, Dept Virol, PL-20093 Lublin, Poland
关键词
fused 1,2,4-triazine esters; antibacterial activity; cytotoxicity; GMK cells; HEK-293; cells; antiviral activity; human adenovirus type-5; human enterovirus echo-9; in vitro study;
D O I
10.1016/j.bmc.2007.05.048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The in vitro biological activities of novel derivatives of methyl and ethyl 2-(4-oxo-8-aryl-2H-3,4,6,7-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetates (3a, 3d-j) have been evaluated and are reported. The final heterobicycles (3a-j) were obtained from monocyclic 1-aryl-2-hydrazonoimidazolidines (2a-f) by addition and cyclization reaction with fumaric acid esters. In particular, compounds 3d and 3e were found to exhibit comparable antibacterial potencies in vitro as that of ampicillin. Heterobicycles of the 3e, 3g and 3j type were screened for their antiviral activities against the selected viruses' DNA (human adenovirus type 5-Ad-5) and RNA (human enterovirus-Echo-9). Simultaneously, their cytotoxicities towards HEK-293 and GMK cells were established. In particular, heterobicycle 3j, completely non-toxic for GM K cells, was found to exhibit virucidal properties against Echo-9 virus justifying its further investigation as the potential antiviral agent. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5480 / 5486
页数:7
相关论文
共 40 条
[31]  
SZTANKE K, 2004, Patent No. 365356
[32]  
SZTANKE K, 2005, Patent No. 373356
[33]   Novel derivatives of methyl and ethyl 2-(4-oxo-8-aryl-2H-3,4,6,7-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetates from biologically active 1-aryl-2-hydrazinoimidazolines:: Synthesis, crystal structure and antiproliferative activity [J].
Sztanke, Krzysztof ;
Rzymowska, Jolanta ;
Niemczyk, Maciej ;
Dybala, Izabela ;
Koziol, Anna E. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2006, 41 (12) :1373-1384
[34]   Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate [J].
Sztanke, Krzysztof ;
Rzymowska, Jolanta ;
Niemczyk, Maciej ;
Dybala, Izabela ;
Koziol, Anna E. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2006, 41 (04) :539-547
[35]   Synthesis of imidazoline and imidazo[2,1-c][1,2,4]triazole aryl derivatives containing the methylthio group as possible antibacterial agents [J].
Sztanke, Krzysztof ;
Pasternak, Kazimierz ;
Sidor-Wojtowicz, Anna ;
Truchlinska, Janina ;
Jozwiak, Krzysztof .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (11) :3635-3642
[36]  
Sztanke Krzysztof, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P96
[37]   Amyloid β-peptide-induced inhibition of MTT reduction in PC12h and C1300 neuroblastoma cells:: Effect of nitroprusside [J].
Takenouchi, T ;
Munekata, E .
PEPTIDES, 1998, 19 (02) :365-372
[38]  
WALTERS TR, 1972, CANCER-AM CANCER SOC, V29, P1057, DOI 10.1002/1097-0142(197204)29:4<1057::AID-CNCR2820290455>3.0.CO
[39]  
2-Q
[40]  
Wiley P. F., 1978, CHEM HETEROCYCL COMP, V33, P189